Bharat Biotech’s Covid-19 nasal vaccine phase III trials completed | India News
PARIS: Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the Covid-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller…
